TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA), a medical technology company specializing in tissue reinforcement materials, will participate in the Canaccord Genuity 40th Annual Growth Conference from August 11-13, 2020. Management is set to present on August 13 at 1:30 p.m. ET. The conference will be held virtually, and interested parties can access the live webcast through the company's website. TELA Bio focuses on addressing unmet needs in soft tissue reconstruction with innovative products backed by extensive research.

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announces today it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020. TELA Bio's management is scheduled to present on Thursday, August 13, 2020, at 1:30 p.m. Eastern Time. Interested parties may access a live audio webcast of the presentation by visiting the "Investors" section of the company's website at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. TELA's products are designed to improve on shortcomings of existing biologics and minimize long-term exposure to permanent synthetic material. TELA's portfolio is supported by quality, data-driven science and extensive pre-clinical research that has consistently demonstrated advantages over other commercially available products.

TELA Bio Contact
Stuart Henderson
Vice President, Corporate Development and Investor Relations
TELA Bio, Inc.
484-320-2930

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com

 

FAQ

When is TELA Bio's presentation at the Canaccord Genuity conference?

TELA Bio's presentation is scheduled for August 13, 2020, at 1:30 p.m. Eastern Time.

How can I access the TELA Bio conference presentation?

You can access the live audio webcast of TELA Bio's presentation by visiting the 'Investors' section on their website.

What is TELA Bio focused on?

TELA Bio is focused on designing and marketing new tissue reinforcement materials for soft tissue reconstruction.

What are the dates for the Canaccord Genuity 40th Annual Growth Conference?

The Canaccord Genuity 40th Annual Growth Conference will take place from August 11 to August 13, 2020.

What is the stock symbol for TELA Bio?

The stock symbol for TELA Bio is TELA, and it is traded on NASDAQ.